🛡️ Healing & Regeneration
4 peptides in this category
BPC-157
BPC-157 is a synthetic peptide derived from a sequence found in human gastric juice. It has been extensively studied in rodent models for its effects on healing, angiogenesis, and inflammation reduction. Though widely researched, it is not approved for human or veterinary use.
Standard dose: 500 mcg SubQ or 1 mg orally, administered daily.
ARA-290
ARA-290 is a non-erythropoietic peptide derived from erythropoietin that targets the innate repair receptor (IRR) to reduce inflammation and promote healing, particularly in neuropathic pain, cardiovascular inflammation, and microvascular dysfunction. It avoids stimulating red blood cell production, making it safer for chronic therapeutic use.
Standard dose: 4 mcg/kg SubQ daily for 4 weeks.
TB-500
TB-500 is a synthetic peptide modeled after Thymosin Beta-4 that promotes tissue regeneration, reduces inflammation, and supports recovery in musculoskeletal injuries. It is often used by researchers and clinicians for its potent actin-binding properties and ability to enhance healing in muscles, tendons, ligaments, and even cardiac tissue.
Standard dose: 2.5 mg SubQ every other day for 4-6 weeks (loading), then 2 mg weekly (maintenance).
Thymosin Beta-4
Thymosin Beta-4 is an endogenous peptide critical for cellular repair and cytoskeletal regulation. It plays a key role in tissue regeneration, inflammation control, and angiogenesis. Distinct from synthetic TB-500 fragments, full-length TB4 is being studied for cardiac recovery, neurological healing, and advanced wound care.
Typical dose: 2 mg SubQ 1–2x weekly for 4–6 weeks. Higher doses used in acute injury or surgery.